Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Bone Marrow Transplantation|April 1, 1994
Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantationA Maruta, H Kanamori, H Fukawa, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemiaS Arimori, H Terada, K Hayami, et al.Bone Marrow Transplantation|May 1, 1991
Donor-HLA-incompatible marrow transplantation with an anti-donor cytotoxic antibody in the serum of the patientA Maruta, H Fukawa, H Kanamori, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1993
[Neutrophilic myelofibrosis; a case report]R Okamoto, H Harano, T Tamura, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1995
[Therapy related leukemia]S Fujisawa, A Maruta, R Sakai, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1991
[Clinical effects of low-dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes]H Kanamori, A Maruta, H Fukawa, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1995
[Treatment for elderly patients with acute non-lymphocytic leukemia]S Fujisawa, A Maruta, K Ogawa, et al.Gan|October 1, 1983
Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienolsM Kuwano, K Ikezaki, K Mamizuka, et al.Journal of the National Cancer Institute|October 1, 1984
Potentiation of anticancer agents by new synthetic isoprenoids. II. Inhibition of the growth of transplantable murine tumorsT Yamaguchi, K Ikezaki, T Kishiye, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1992
[Myelodysplastic syndrome associated with marked eosinophilia and basophilia]J Tanabe, S Sasaki, T Tamura, et al.Pageof 4